BEAM-302 updated Phase I/II data show durable AAT restoration
Updated Phase I/II data for BEAM-302 in AATD report durable, functional AAT restoration, significant reduction of Z-AAT and Z-polymers, and a favorable safety profile. The pivotal global cohort is enrolling rapidly, with regulatory alignment for accelerated approval.
Updated phase I/II data for BEAM-302 in AATD show durable, functional AAT restoration, significant reduction in disease-driving Z-AAT and Z-polymers, and a favorable safety profile. The pivotal global cohort is enrolling rapidly, with regulatory alignment for accelerated approval and strong financi…